Works matching IS 17437555 AND DT 2015 AND VI 11 AND IP 1


Results: 15
    1
    2
    4
    5
    6

    Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2015, v. 11, n. 1, p. 4, doi. 10.1111/ajco.12178
    By:
    • Michael, Michael;
    • White, Shane C;
    • Abdi, Ehtesham;
    • Nott, Louise;
    • Clingan, Phillip;
    • Zimet, Allan;
    • Button, Peter;
    • Gregory, Daniel;
    • Solomon, Benjamin;
    • Dobrovic, Alexander;
    • Do, Hongdo;
    • Clarke, Stephen
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    In this issue.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2015, v. 11, n. 1, p. i, doi. 10.1111/ajco.12412
    By:
    • Ma, Jessica
    Publication type:
    Article
    13
    14
    15